Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer

by NASDAQ Market News April 13, 2020

NASDAQ Market News
Click here to email author

Arvinas Provides Update on Business Continuity Related to the Impact of the COVID-19 Pandemic

BeiGene Announces that the Phase 3 Trial of Tislelizumab Combined with Chemotherapy in Patients with First-Line Non-Squamous Non-Small Cell Lung Cancer Met the Primary Endpoint of Progression-Free Survival at Interim Analysis

Ads